Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pohl

Showing results (31-40 of 305) with videos related to

Pageof 31
Sort By:
Zeitschrift Fur Gastroenterologie|February 24, 2001
[Pulmonal sarcoidosis: A rare side effect of interferon-alpha treatment for chronic hepatitis C infection]J Pohl, W Stremmel, B Kallinowski
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The development of alkylphosphocholines as signal transduction inhibitors: experimental and clinical challengesP Hilgard, J Pohl, J Engel
Journal of Chromatography|April 11, 1986
Separation of human pepsin and gastricsin by affinity chromatography with an immobilized synthetic inhibitorZ Kucerová, J Pohl, L Korbová
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Basic principles in preclinical cancer chemotherapyN Brock, J Pohl, B Schneider
Analytical Biochemistry|September 1, 1980
A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractionsR J Pohl, J R Fouts
Journal of Cancer Research and Clinical Oncology|January 1, 1981
Detoxification of urotoxic oxazaphosphorines by sulfhydryl compoundsN Brock, J Pohl, J Stekar
Urologia Internationalis|January 1, 1991
In vivo measurement of force in the ureter. I. Basics of a new measurement principleJ Pohl, U Dambacher, G Marx
Cancer Treatment Reviews|June 1, 1984
alpha-/beta-Triglycidyl-urazol (TGU, NSC 332488, I.N.N.: ANAXIRONE): a new chemotherapeutic agentP Hilgard, M Peukert, J Pohl
European Journal of Cancer|June 1, 1981
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compoundsN Brock, J Pohl, J Stekar
Arzneimittel-Forschung|June 1, 1989
Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communicationJ Pohl, J Stekar, P Hilgard
Pageof 31

Showing results (31-40 of 305) with videos related to

Sort By:
Pageof 31
Zeitschrift Fur Gastroenterologie|February 24, 2001
[Pulmonal sarcoidosis: A rare side effect of interferon-alpha treatment for chronic hepatitis C infection]J Pohl, W Stremmel, B Kallinowski
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The development of alkylphosphocholines as signal transduction inhibitors: experimental and clinical challengesP Hilgard, J Pohl, J Engel
Journal of Chromatography|April 11, 1986
Separation of human pepsin and gastricsin by affinity chromatography with an immobilized synthetic inhibitorZ Kucerová, J Pohl, L Korbová
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Basic principles in preclinical cancer chemotherapyN Brock, J Pohl, B Schneider
Analytical Biochemistry|September 1, 1980
A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractionsR J Pohl, J R Fouts
Journal of Cancer Research and Clinical Oncology|January 1, 1981
Detoxification of urotoxic oxazaphosphorines by sulfhydryl compoundsN Brock, J Pohl, J Stekar
Urologia Internationalis|January 1, 1991
In vivo measurement of force in the ureter. I. Basics of a new measurement principleJ Pohl, U Dambacher, G Marx
Cancer Treatment Reviews|June 1, 1984
alpha-/beta-Triglycidyl-urazol (TGU, NSC 332488, I.N.N.: ANAXIRONE): a new chemotherapeutic agentP Hilgard, M Peukert, J Pohl
European Journal of Cancer|June 1, 1981
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compoundsN Brock, J Pohl, J Stekar
Arzneimittel-Forschung|June 1, 1989
Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communicationJ Pohl, J Stekar, P Hilgard
Pageof 31